Position in RIGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,278,234
+$4,604,847 QoQ
Shares Held
186,049
+88.2% QoQ
Ownership
0.996%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,792 across 523 Biotechnology names. RIGL ranks #151 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in RIGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,278,234 | 186,049 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,673,387 | 98,868 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,130,721 | 166,489 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,143,713 | 146,266 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $28,473,661 | 1,520,217 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $27,650,393 | 1,536,987 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $26,264,360 | 1,561,496 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $23,679,412 | 1,463,499 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $11,712,312 | 1,424,856 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $21,372,466 | 14,440,858 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $20,959,912 | 14,455,114 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $7,541,071 | 6,982,475 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $4,984,971 | 3,864,321 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $659,751 | 499,813 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $907,385 | 604,925 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,065,030 | 902,570 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,473,540 | 2,188,978 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,398,132 | 1,136,500 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,299,954 | 867,909 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,858,817 | 1,063,036 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,091,252 | 1,403,515 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $4,728,418 | 1,382,579 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $18,288,560 | 5,225,303 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $6,949,709 | 2,895,713 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,493,430 | 1,362,531 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,918,062 | 2,511,579 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||